New CMS TCET Rule Likely Won’t Hasten Medicare Coverage of Breakthrough Devices
Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.
CMS-nir
Subscribe today for access to
Articles and Reports
Proposed Rule Puts Labs at Greater Risk of FCA Liability
CMS recently proposed a rule that would make the False Claims Act rule the standard for overpayments under the Affordable Care Act regulations.
CMS Proposes Modest Increase to Hospital IPPS Rates
Unsurprisingly, the American Hospital Association and other industry groups don’t think that increase is anywhere near adequate.
Medicare Seeks Input on More Than 100 New Lab Test Codes
...
Already a member? Log in here
Aetna Cuts Pathology Reimbursement To 70% of Medicare
...
Already a member? Log in here
Colon Cancer Screening Test Gets FDA Approval, Proposed Medicare Coverage
...
Already a member? Log in here
FDA Plans to Regulate Lab-Developed Tests Could Increase Time and Cost of Development
In its July 31 notice to Congress, the agency says it would phase in oversight requirements over nine years.
Labs Finalizing Policies and Procedures Under Patient Access Rule
...
Already a member? Log in here
Medicare Payments to Hospital Outpatient Labs Showing Huge Shift
...
Already a member? Log in here
CAP Opposes Proposals to Package Ancillary Services
...
Already a member? Log in here
Groups Weigh In on PFS; LCDs, 88185, Prostate Biopsy Code Among Concerns
...
Already a member? Log in here